Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Management of Insomnia01:19

Management of Insomnia

243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
Seizures: Classification01:13

Seizures: Classification

331
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
331
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are we treating? The need for broader provider understanding of POTS, its nature, and care.

The American journal of medicine·2026
Same author

Indications, contraindications, and step-by-step methodology for performing carotid sinus massage in patients presenting with syncope : A scientific statement of an Ad Hoc Syncope Consortium endorsed by: the European Autonomic Society (EFAS), Gruppo Italiano Multidisciplinare Syncope (GIMSI) and European Geriatric Medicine Society (EuGMS).

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026
Same author

Chasing Down the Bleed: A Jejunal Gastrointestinal Stromal Tumor Missed for Nearly a Decade and Treated With Argon Plasma Coagulation.

ACG case reports journal·2026
Same author

Clinical outcomes of rate control versus rhythm control as the initial strategy in atrial fibrillation: insights from the GLORIA-AF registry.

Internal and emergency medicine·2026
Same author

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III.

Journal of the American Heart Association·2026
Same author

Stylet-in-sheath: A new solution to an old problem?

Heart rhythm·2026

Related Experiment Video

Updated: Jun 22, 2025

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.7K

Can Artificial Intelligence Enhance Syncope Management?: A JACC: Advances Multidisciplinary Collaborative Statement.

Giselle M Statz1, Aron Z Evans2, Samuel L Johnston1

  • 1Division of Cardiovascular Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

JACC. Advances
|June 28, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) may improve syncope management by aiding diagnosis and risk assessment. This can lead to better patient outcomes and reduced healthcare costs, though challenges remain.

Keywords:
artificial intelligenceemergency departmentmachine learningsyncopetransient loss of consciousness

More Related Videos

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.2K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K

Related Experiment Videos

Last Updated: Jun 22, 2025

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.7K
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.2K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K

Area of Science:

  • Cardiology
  • Medical Informatics

Background:

  • Syncope (transient loss of consciousness) presents diagnostic and risk stratification challenges.
  • Current algorithms often lead to unnecessary hospitalizations and high costs.
  • Adverse cardiovascular outcomes, though concerning, are rare in syncope patients.

Purpose of the Study:

  • To explore the potential of Artificial Intelligence (AI) in syncope management.
  • To highlight AI's role in improving diagnosis, risk assessment, and treatment decisions.
  • To encourage the development of AI-driven clinical decision support tools for syncope.

Main Methods:

  • This is a collaborative statement from a multidisciplinary group.
  • Focuses on the potential applications and challenges of AI in syncope.
  • Reviews current limitations in syncope risk stratification and management.

Main Results:

  • AI may enhance the definition and diagnosis of transient loss of consciousness events.
  • AI tools could predict syncope recurrence and guide hospitalization decisions.
  • Potential exists for AI to streamline diagnostics and reduce healthcare expenses.

Conclusions:

  • AI offers significant promise for optimizing syncope patient care.
  • Development of AI-derived tools can improve outcomes and efficiency.
  • Addressing medicolegal and ethical concerns is crucial for AI implementation in syncope.